PerkinElmer said this week that it has completed its acquisition of Caliper Life Sciences for around $600 million.
The agreement, which was announced in September, will, among other things, allow PerkinElmer to combine its expertise in informatics with Caliper's automation and sample-prep technology to bolster PerkinElmer's presence in the next-generation sequencing space (IS 9/13/2011).
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
